KINDRED BIOSCIENCES, INC.: 10-Q filed 2014-05-14
What KINDRED BIOSCIENCES, INC. reported in its quarterly report filed 2014-05-14 (fiscal Q1 2014): 21 published measures, 54 facts as tagged in accession 0001561743-14-000033.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-05-14
- Fiscal period
- fiscal Q1 2014
- Accession
- 0001561743-14-000033 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KINDRED BIOSCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 61,120,000 | USD | |
| At 2013-12-31 | 65,489,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 2,629,000 | USD | |
| At 2013-12-31 | 2,210,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 58,491,000 | USD | |
| At 2013-12-31 | 63,279,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 36,513,000 | USD | |
| At 2013-12-31 | 65,329,000 | USD | |
| At 2013-03-31 | 787,000 | USD | |
| At 2012-12-31 | 938,000 | USD | |
| At 2012-09-24 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -6,168,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | -10,501,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | -224,000 | USD | 90 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 19,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 34,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | -10,501,000 | USD | |
| At 2013-12-31 | -4,333,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 27,000 | USD | |
| At 2013-12-31 | 12,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 1,077,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 2,010,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 39,000 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -6,177,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | -10,516,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | -224,000 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 61,093,000 | USD | |
| At 2013-12-31 | 65,477,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 1,671,000 | USD | |
| At 2013-12-31 | 689,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 6,177,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 10,516,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 224,000 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 4,498,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 7,713,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 141,000 | USD | 90 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 68,990,000 | USD | |
| At 2013-12-31 | 67,610,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 958,000 | USD | |
| At 2013-12-31 | 1,521,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-03-31 | 565,000 | USD | |
| At 2013-12-31 | 148,000 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | -6,168,000 | USD | 90 |
| 2013-01-01 to 2013-03-31 | -224,000 | USD | 90 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 1,679,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 2,803,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 83,000 | USD | 90 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 4,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 7,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | 0 | USD | 90 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-03-31 | 982,000 | USD | 90 |
| 2012-09-25 to 2014-03-31 | 1,670,000 | USD | 553 |
| 2013-01-01 to 2013-03-31 | -4,000 | USD | 90 |
Inspect the source
- Entity
- KINDRED BIOSCIENCES, INC. / CIK 0001561743
- Captured
- SEC response SHA-256
7c581415317deffa64c7e5dca456314fc73425a22b98fdb238e90b28fd457071
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001561743.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))